David Savage, MD
Orthopaedic Surgery · Austin, TXNPI 1346259199
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (45.4%), travel and lodging and education — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Lilly USA, LLC at 55.0% of the total. Reporting peaked in 2019 at $6,540 and has fallen 99.5% since, to $32 in 2025.
Across 44 payments — averaging $187.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$5K
- Stryker$2K
- Medinc Of Texas$1K
- Zimmer Biomet$149
- Heron Therapeutics, Inc.$89
- Pfizer$66
- plus $226 from 9 others
Across 1 payment — averaging $100.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$100
What the payments were for
- Consulting fees$3,75045%
- Travel & lodging$2,14426%
- Food & beverage$1,16914%
- Education$1,20015%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 11 | $4,545 |
| Stryker | 18 | $1,987 |
| Medinc Of Texas | 1 | $1,200 |
| Zimmer Biomet | 1 | $149 |
| Heron Therapeutics, Inc. | 1 | $89 |
| Pfizer | 1 | $66 |
| Linvatec Corporation | 1 | $39 |
| Ferring Pharmaceuticals Inc. | 2 | $39 |
| Pacira Pharmaceuticals Incorporated | 1 | $34 |
| Si-bone, Inc. | 2 | $33 |
| Total Joint Orthopedics, Inc. | 1 | $32 |
| Medtronic | 1 | $25 |
| Actelion Pharmaceuticals US, Inc. | 1 | $11 |
| ERMI LLC | 1 | $10 |
| Orthofix Medical, Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$1,677
How this compares
$8,263 in reported general payments places this provider in the 60th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 180 | $515 |
| Tramadol Hcl | 126 | $439 |
| Oxycodone Hcl | 91 | $386 |
| Methylprednisolone | 57 | $331 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $186 |
| Mupirocin | 16 | $70 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Austin
- Robert GrahamAustin$6.3M
- Eric HeinrichAustin$907K
- David DodginAustin$704K
- Stephen BurkhartSan Antonio$185.3M
- Kirby HittTemple$9.1M
- Richard JonesDallas$6.3M
- Stefan KreuzerHouston$6.2M
- Michael WirthSan Antonio$4.5M
- Stephen IncavoHouston$4.3M
- Thomas EdwardsHouston$4.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.